IDC - Institute for Diabetes and Cancer

Startseite
Deutschland
Oberschleißheim
IDC - Institute for Diabetes and Cancer

The IDC is investigating the molecular basis of severe metabolic disorders, including the Metabolic Syndrome and Type 2 Diabetes and their roles in cancer.

The Institute for Diabetes and Cancer (IDC) is a member of the Helmholtz Diabetes Center (HDC) at the Helmholtz Center Munich and also a partner within the Joint Heidelberg-IDC Translational Diabetes Program. The Institute for Diabetes and Cancer is tightly integrated into the German Center for Diabetes Research (DZD) and the Collaborative Research Center SFB 1118 “Reactive metabolites and diabetic complications” at the University Medicine Heidelberg, Germany. The IDC is investigating the molecular basis of severe metabolic disorders, including the Metabolic Syndrome and Type 2 Diabetes, and their roles in tumor initiation and progression. The main causes of these metabolic disorders are believed to be malfunctions in the activity of genes regulating our metabolism. By analyzing the signal-dependent activity of such genes in response to hormonal, nutritional and inflammatory cues, we aim to define disease-causing malfunctions in glucose, fat and protein metabolism, ultimately aiming at the identification of genes, gene products and associated signaling pathways which increase the susceptibility to metabolic diseases. Subsequently, identified gene defects are tested for their potential to serve as molecular connections between metabolic and tumor diseases and as novel drug targets within these disease entities. By using a translational research approach in collaboration with an extensive academic, clinical and pharmaceutical partner network, we anticipate unravelling clinically significant molecular determinants in the pathogenesis of the Metabolic Syndrome and Type 2 Diabetes that are directly coupled to increased cancer risk. The IDC divisions and junior groups will focus on four main areas:

1. Molecular metabolic mechanisms contributing to diabetic complications
2. Molecular and cellular determinants of adipose tissue function
3. Systemic and cellular mechanisms controlling tumor metabolism
4. Cellular trafficking and metabolic control
5. Neuroendocrinology

13/06/2019

We proudly announce that the "7th Helmholtz Diabetes Conference" is taking place in Palais Lenbach, Munich, from September 23 – 25, 2019. Check out the details here:

We use cookies to improve your experience on our Website. We need cookies to continuously improve the services, to enable certain features and when embedding services or content of third parties, such as video player. By using our website, you agree to the use of cookies. We use different types of c...

14/11/2018

Today is . Are you aware that over 8% of the world population is suffering from , mainly caused by an unhealthy ? Check out our video and website for more information. https://www.helmholtz-muenchen.de/hdc/index.html

15/10/2018

12/09/2018

What a popular topic!
Prof. Herzig has just given another interview about intervall fasting. .
Check out "W wie wissen" in "das Erste":
https://www.daserste.de/information/wissen-kultur/w-wie-wissen/videos/intervallfasten-video-100.html

23/08/2018

Are you interested in interval fasting?
Check out Prof. Herzig's 15 minute talk at "Campus Talks" on Bayerischer Rundfunk (only in German):

Fasten und hungern kann gut für unsere Gesundheit sein. Wie sieht so eine kontrollierte Hungertherapie aus und welche Erkenntnisse können für Stoffwechselerkrankungen daraus gewonnen werden?

03/08/2018

The IDC has just been on a Retreat at Hotel Riessersee for one night in order to exchange and discuss the latest news in the Diabetes and Cancer research field.

05/07/2018

The IDC is currently searching for a new Technical Assistant: https://bms.candibase.de/atool/helmholtz/frontend.php?view=a2f57f80bc29a1233f6ede911bde4457&lang=de&

If you are interested, please feel free to send an application!

Helmholtz sucht Technische/n Mitarbeiter/in - VMTA/BTA/CTA/MTA, Laborant/in oder vergleichbar für Neuherberg bei München

05/07/2018

Congratulations to our PhD student Jessica Chan, who has recently successfully defended her thesis!!

02/07/2018

Our postdoc Maude Giroud has just visited the “68th Lindau Nobel Laureate Meeting”, which a lot of Nobel Prize winners (including Bruce A. Beutler, J. Michael Bishop and Elizabeth H. Blackburn), had attended: www.lindau-nobel.org

Her poster with the title "Non-coding RNAs are important regulators of adipocyte plasticity" was one of the 30 selected ones out of 400.

Congratulations!

03/05/2018

The new "International Helmholtz Research School for Diabetes" (RSD) is now online. The first international call will take place next Thursday, 10th of May (deadline is June 29th 2018).

Check it out: www.helmholtzresearchschool-diabetes.org

12/04/2018

Pauline Morigny wins poster price at "7th International Graz symposium on Lipid and Membrane Biology (SFB Lipotox)". Congratulations! :-)

11/04/2018

Check out the article "Wie Übergewicht Krebs aggressiver macht" on DocCheck News about our breast cancer study:

http://news.doccheck.com/de/205980/wie-uebergewicht-krebs-aggressiver-macht/?utm_source=Facebook+DocCheck+News&utm_medium=urlshortener&utm_campaign=Wie+%C3%9Cbergewicht+Krebs+aggressiver+macht

This article is only available in German.

Adresse

Ingolstädter LandStr. 1
Oberschleißheim
85764

Telefon

+498931871046

Webseite

http://www.helmholtz-muenchen.de/en/idc/index.html

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von IDC - Institute for Diabetes and Cancer erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.